ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 18.90
+0.25 (1.34%)
Aug 7, 2026, 1:30 PM CST
ScinoPharm Taiwan Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,499 | 3,110 | 4,166 | 3,942 | 4,295 | 4,081 |
Cash & Short-Term Investments | 3,499 | 3,110 | 4,166 | 3,942 | 4,295 | 4,081 |
Cash Growth | 13.37% | -25.35% | 5.70% | -8.22% | 5.24% | 0.64% |
Accounts Receivable | 347.19 | 612.41 | 633.62 | 788.22 | 635.26 | 360.25 |
Other Receivables | 22.53 | 11.62 | 20.57 | 25.23 | 18.28 | 32.8 |
Receivables | 369.72 | 624.03 | 654.19 | 813.45 | 653.55 | 393.04 |
Inventory | 1,820 | 1,637 | 1,673 | 1,512 | 1,189 | 1,345 |
Prepaid Expenses | 139.14 | 119.99 | 114.91 | 105.79 | 132.24 | 96.85 |
Other Current Assets | - | 0.09 | - | 8.3 | 51.13 | 50.71 |
Total Current Assets | 5,827 | 5,491 | 6,608 | 6,381 | 6,320 | 5,967 |
Property, Plant & Equipment | 4,114 | 4,083 | 4,426 | 4,399 | 4,498 | 4,648 |
Long-Term Investments | 1,574 | 1,368 | 70.13 | 69.97 | 112.62 | 185.8 |
Other Intangible Assets | 12.87 | 15.36 | 17.13 | 19.15 | 9.95 | 8.79 |
Long-Term Deferred Tax Assets | 695.51 | 664.63 | 625.26 | 640.93 | 637.44 | 614.98 |
Other Long-Term Assets | 136.61 | 236.22 | 196.6 | 211.48 | 332.96 | 267.07 |
Total Assets | 12,360 | 11,858 | 11,943 | 11,722 | 11,911 | 11,691 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 177.75 | 62.53 | 82.17 | 102.46 | 126.5 | 70.86 |
Accrued Expenses | - | 105.53 | 143.45 | 139.78 | 139.6 | 124.62 |
Short-Term Debt | 185.24 | 130.42 | 35.56 | 32.14 | 77.6 | - |
Current Portion of Leases | 23.29 | 23.46 | 19.64 | 17.56 | 17.89 | 16.17 |
Current Income Taxes Payable | 21.98 | 14.5 | 11.5 | 62.6 | 99.64 | 71.17 |
Current Unearned Revenue | 234.64 | 115.35 | 119.4 | 110.97 | 67.75 | 70.57 |
Other Current Liabilities | 585.82 | 258.05 | 355.97 | 263.96 | 274.12 | 202.93 |
Total Current Liabilities | 1,229 | 709.84 | 767.68 | 729.45 | 803.09 | 556.31 |
Long-Term Leases | 664.36 | 608.78 | 620.34 | 570.23 | 581.18 | 540.27 |
Pension & Post-Retirement Benefits | - | 10.69 | 23.61 | 54.51 | 74.49 | 79.55 |
Long-Term Deferred Tax Liabilities | 1.21 | 0.63 | 1.3 | 1.66 | - | 0.35 |
Other Long-Term Liabilities | 4.31 | 3.05 | 3.99 | 1.3 | 2.36 | 3.65 |
Total Liabilities | 1,899 | 1,333 | 1,417 | 1,357 | 1,461 | 1,180 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 7,907 | 7,907 | 7,907 | 7,907 | 7,907 | 7,907 |
Additional Paid-In Capital | 1,295 | 1,295 | 1,295 | 1,295 | 1,295 | 1,295 |
Retained Earnings | 1,062 | 1,310 | 1,450 | 1,348 | 1,346 | 1,370 |
Comprehensive Income & Other | 197.31 | 12.32 | -126.18 | -185.86 | -98.18 | -61.13 |
Shareholders' Equity | 10,461 | 10,525 | 10,526 | 10,364 | 10,450 | 10,511 |
Total Liabilities & Equity | 12,360 | 11,858 | 11,943 | 11,722 | 11,911 | 11,691 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 872.89 | 762.66 | 675.54 | 619.92 | 676.67 | 556.43 |
Net Cash (Debt) | 2,626 | 2,347 | 3,490 | 3,322 | 3,618 | 3,524 |
Net Cash Growth | 11.14% | -32.75% | 5.08% | -8.19% | 2.65% | 1.31% |
Net Cash Per Share | 3.03 | 2.96 | 4.40 | 4.19 | 4.56 | 4.45 |
Filing Date Shares Outstanding | 888.2 | 790.74 | 790.74 | 790.74 | 790.74 | 790.74 |
Total Common Shares Outstanding | 888.2 | 790.74 | 790.74 | 790.74 | 790.74 | 790.74 |
Working Capital | 4,598 | 4,781 | 5,840 | 5,651 | 5,517 | 5,410 |
Book Value Per Share | 11.78 | 13.31 | 13.31 | 13.11 | 13.22 | 13.29 |
Tangible Book Value | 10,449 | 10,509 | 10,509 | 10,345 | 10,440 | 10,502 |
Tangible Book Value Per Share | 11.76 | 13.29 | 13.29 | 13.08 | 13.20 | 13.28 |
Buildings | - | 4,318 | 4,309 | 4,249 | 4,095 | 3,546 |
Machinery | - | 6,862 | 6,647 | 6,432 | 6,249 | 5,641 |
Construction In Progress | - | 52.08 | 194.04 | 77.72 | 155.62 | 1,119 |